4554--富士製薬-【医薬品】【後発医薬品】不妊症治療剤とX線診断用の血管造影剤

売上高:461380-当期純利益:61460-総資産:900000-時価:34284013----Yahoo

intdate初値高値安値終値出来高前日比価格比終/初値出来比upv5%s10%s20%sper_pp_15率10率MAX20MIN20
202506241,3261,3301,3181,32517,8005100%100%51%300101%105%105%99%3%
202506251,3221,3311,3191,33024,4005100%101%137%▲▲200102%97%100%100%3%
202506261,3901,4231,3641,416257,20086106%102%1054%▲▲▲00099%94%97%100%10%
202506271,4301,4321,4021,415127,800-1100%99%50%00098%95%98%100%10%
202506301,4111,4151,3821,38678,400-2998%98%61%▼▼00098%97%100%98%8%
202507011,3801,3801,3441,35558,700-3198%98%75%▼▼▼000100%99%103%96%5%
202507021,3421,3541,3391,34846,500-799%100%79%▼▼▼▼00099%99%103%95%5%
202507031,3481,3541,3221,33768,200-1199%99%147%▼▼▼▼▼000101%100%104%94%4%
202507041,3331,3511,3321,34224,8005100%101%36%00099%99%103%95%4%
202507071,3421,3451,3301,33153,100-1199%99%214%000100%101%104%94%3%
202507081,3261,3281,3181,32342,100-899%100%79%▼▼000100%101%0%93%2%
202507091,3261,3361,3221,33233,7009101%100%80%00099%100%0%94%1%
202507101,3311,3321,3211,32439,800-899%99%118%000100%102%0%94%0%
202507111,3251,3471,3251,32738,7003100%100%97%000100%101%0%94%1%
202507141,3351,3461,3291,34023,70013101%100%61%▲▲000100%103%0%95%2%
202507151,3401,3431,3261,33584,400-5100%100%356%00099%104%0%94%1%
202507161,3341,3341,3211,32558,300-1099%99%69%▼▼000102%104%0%94%0%
202507171,3261,3501,3261,35056,50025102%102%97%00099%0%0%95%2%
202507181,3611,3691,3451,347109,300-3100%99%193%000103%0%0%95%2%
202507221,3451,3881,3401,380129,90033102%103%119%000100%0%0%97%4%
202507231,3851,3891,3671,385110,9005100%100%85%▲▲000%%%98%5%

TDnet更新情報

報告日strtime銘柄タイトル
2025071716:30富士製薬 行使価額修正条項付第1回新株予約権の取得及び消却に関するお知らせ
2025050816:30富士製薬 2025年9月期第2四半期(中間期)決算短信〔日本基準〕(連結)
2025020616:00富士製薬 2025年9月期第1四半期決算短信〔日本基準〕(連結)
2024112615:30富士製薬 (訂正)中期経営計画の策定並びに「資本コストや株価を意識した経営の実現に向けた対応」に関するお知らせの一部訂正について
2024112517:00富士製薬 中期経営計画の策定並びに資本コストや株価を意識した経営の実現に向けた対応に関するお知らせ
2024111216:00富士製薬 2024年9月期決算短信〔日本基準〕(連結)
2024111216:00富士製薬 60周年記念配当および2025年9月期の配当予想に関するお知らせ
2024080816:30富士製薬 2024年9月期第3四半期決算短信〔日本基準〕(連結)
2024080817:00富士製薬 株式報酬制度の継続に伴う第三者割当による自己株式の処分に関するお知らせ
2024080817:00富士製薬 株式報酬制度における株式取得に係る事項の決定に関するお知らせ
2024071816:30富士製薬 第三者割当による第1回乃至第3回新株予約権の発行に関するお知らせ
2024062016:40富士製薬 代表取締役の異動に関するお知らせ
2024050917:00富士製薬 2024年9月期第2四半期決算短信〔日本基準〕(連結)
2024050917:00富士製薬 第2四半期業績予想と実績の差異および通期業績予想の一部修正に関するお知らせ
2024020817:00富士製薬 2024年9月期第1四半期決算短信〔日本基準〕(連結)

機関空売り情報

報告日空売り機関残高割合増減初値高値安値終値出来高
2025-05-13 Barclays Capital Securities Ltd121,0430.48%-9,1001,3081,3171,2711,273106,100
2025-05-09 Barclays Capital Securities Ltd130,1430.52%8,0001,3011,3371,3011,310174,100
2025-04-10 Barclays Capital Securities Ltd122,1430.49%-24,6001,3151,3201,2901,30661,500
2025-02-25 Barclays Capital Securities Ltd146,7430.59%-25,5001,3271,3571,3271,35455,500
2025-02-12 MERRILL LYNCH INTERNATIONAL121,5220.48%-25,9001,3751,3871,3601,383115,100
2025-02-12 MERRILL LYNCH INTERNATIONAL121,5220.48%-25,9001,3751,3871,3601,383115,100
2025-02-10 MERRILL LYNCH INTERNATIONAL147,4220.59%-4,8001,3831,4121,3751,375192,700
2025-02-10 MERRILL LYNCH INTERNATIONAL147,4220.59%1,3831,4121,3751,375192,700
2025-02-07 MERRILL LYNCH INTERNATIONAL152,2220.61%12,6001,3631,3881,3291,380365,900
2025-02-07 MERRILL LYNCH INTERNATIONAL152,2220.61%1,3631,3881,3291,380365,900
2025-02-06 MERRILL LYNCH INTERNATIONAL139,6220.56%1,6001,4211,4681,4151,453122,100
2025-02-06 MERRILL LYNCH INTERNATIONAL139,6220.56%1,4211,4681,4151,453122,100
2025-02-05 MERRILL LYNCH INTERNATIONAL138,0220.55%3,5001,4161,4211,4021,41772,500
2025-02-05 MERRILL LYNCH INTERNATIONAL138,0220.55%1,4161,4211,4021,41772,500
2025-02-04 MERRILL LYNCH INTERNATIONAL134,5220.54%1,4391,4541,4151,41989,000
2025-02-04 MERRILL LYNCH INTERNATIONAL134,5220.54%1,4391,4541,4151,41989,000
2024-11-26 Barclays Capital Securities Ltd172,2430.69%-1,5001,4811,5271,4671,507344,500
2024-09-19 Barclays Capital Securities Ltd173,7430.70%2,0001,2491,2751,2491,26972,100
2024-09-12 Barclays Capital Securities Ltd171,7430.69%1,2491,2701,2421,25261,000
2024-05-16 Integrated Core Strategies (Asia) Pte. Ltd.123,7040.49%-17,1001,5301,5301,5011,51048,600
2024-05-13 Integrated Core Strategies (Asia) Pte. Ltd.140,8040.56%-20,4001,5601,5621,4911,544198,100
2024-05-10 Integrated Core Strategies (Asia) Pte. Ltd.161,2040.65%-30,8001,4811,6151,4781,589348,100
2024-05-01 Integrated Core Strategies (Asia) Pte. Ltd.192,0040.77%-12,4001,5771,6051,5751,59656,200
2024-04-22 Integrated Core Strategies (Asia) Pte. Ltd.204,4040.82%31,1001,5231,5481,5191,53766,700
2024-04-16 Integrated Core Strategies (Asia) Pte. Ltd.173,3040.70%20,2001,5771,5911,5491,550166,200
2024-04-03 Integrated Core Strategies (Asia) Pte. Ltd.153,1040.61%26,0001,5861,6001,5591,582154,200
2024-03-27 Integrated Core Strategies (Asia) Pte. Ltd.127,1040.51%1,6421,6541,6321,636165,100
2024-03-05 JPM Securities Japan Co Ltd.123,1260.49%-13,9001,6651,6821,6441,681152,400

EDINEt更新情報

docIDdocType報告日時企業名提出者報告書
S100U7L53502024-08-13 09:47富士製薬工業株式会社野村證券株式会社変更報告書
S100TBRL3502024-04-25 15:48富士製薬工業株式会社今井 博文変更報告書